Patents by Inventor Fengchao LV

Fengchao LV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EZH2 inhibitor and use thereof
    Patent number: 10647700
    Abstract: An inhibitor of a wild type and Y641F mutant of human histone methyltransferase EZH2 is provided herein. Particularly, the inhibitor is a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. The inhibitor can be used to treat a cancer or precancerous condition related to EZH2 activity.
    Type: Grant
    Filed: January 17, 2018
    Date of Patent: May 12, 2020
    Assignee: TARAPEUTICS SCIENCE INC.
    Inventors: Qingsong Liu, Jing Liu, Fengchao Lv, Chen Hu, Wen Liang Wang, Ao Li Wang, Zi Ping Qi, Xiao Fei Liang, Wen Chao Wang, Tao Ren, Bei Lei Wang, Li Wang
  • EZH2 INHIBITOR AND USE THEREOF
    Publication number: 20190367482
    Abstract: An inhibitor of a wild type and Y641 F mutant of human histone methyltransferase EZH2 is provided herein. Particularly, the inhibitor is a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. The inhibitor can be used to treat a cancer or precancerous condition related to EZH2 activity.
    Type: Application
    Filed: January 17, 2018
    Publication date: December 5, 2019
    Applicant: TARAPEUTICS SCIENCE INC.
    Inventors: Qingsong LIU, Jing LIU, Fengchao LV, Chen HU, Wen Liang WANG, Ao Li WANG, Zi Ping Qi, Xiao Fei LIANG, Wen Chao WANG, Tao REN, Bei Lei WANG, Li WANG